Last reviewed · How we verify
NCT05619419
Study of Affect Induction for Lab Induced Pain in Healthy Undergraduates
NA trial testing Mindfulness-enhanced positive affect induction in Meditation in 180 participants. Completed in 14 November 2022.
14 November 2022
Quick facts
| Lead sponsor | University of Colorado, Denver |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | factorial |
| Masking | none |
| Primary purpose | other |
| Enrollment | 180 |
| Start date | 14 March 2022 |
| Primary completion | 14 November 2022 |
| Estimated completion | 14 November 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Mindfulness-enhanced positive affect induction
- Breathing Meditation
Conditions studied
- Meditation — all drugs for Meditation →
- Pain — all drugs for Pain →
- Mindfulness — all drugs for Mindfulness →
- Affect — all drugs for Affect →
Sponsor
University of Colorado, Denver
Who can join
Adults 18 to 65, any sex, with Meditation or Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to test if a mindfulness-enhanced positive affect induction (MPAI) works well to reduce pain intensity and pain unpleasantness from a cold water pain test in undergraduate college students who do not endorse ongoing medical or mental health diagnoses. The main questions it aims to answer are: * Is the MPAI a feasible and acceptable psychological technique for managing brief pain? * Does the MPAI work well to reduce pain intensity and unpleasantness from experimentally induced brief pain, compared to those using a breathing meditation or those instructed to respond naturally. * Does using the MPAI work well to improve confidence in self-managing brief pain? Participants will be asked to complete questionnaires about their sleep, pain beliefs, and emotions after consenting to participate and at the end of the study session. They will then be randomized to either: * Use the MPAI for managing pain induced by a cold water test (placing their hand in a container of cold water kept at approximately 5 degrees Celsius). * Use a breathing meditation for managing pain induced by a cold water test (placing their hand in a container of cold water kept at approximately 5 degrees Celsius). * Respond naturally to pain induced by a cold water test (placing their hand in a container of cold water kept at approximately 5 degrees Celsius). Researchers will compare the MPAI group to the breathing meditation and natural response groups to see if the MPAI group reports less pain from the cold water test and
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05619419
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Meditation
Currently open trials in the same condition.
- NCT07351799 — Mindfulness and Meditation Based Lactation Education on Maternal Breastmilk in the Neonatal ICU · NA · recruiting
- NCT07201220 — Meditation in Early Labor: Impact on Self-Efficacy and Childbirth Fear in First-Time Mothers · NA · recruiting
- NCT06950905 — Contemplative Practice for Well-being and Self-Deconstruction in Women · NA · recruiting
- NCT05645835 — Dynamic Neural Systems Underlying Social-emotional Functions in Older Adults · NA · active not recruiting
Other University of Colorado, Denver trials
Trials by the same sponsor.
- NCT07292285 — The Surveillance Nonoperative Watch & Wait (SNOWW) Rectal Cancer Trial. · not yet recruiting
- NCT07021937 — Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity · Phase 3 · not yet recruiting
- NCT07453732 — Banana Leaves as a Wound Dressing for Partial Thickness Second Degree Burns in Adult Patients. · NA · not yet recruiting
- NCT07038278 — 5-AminoLevulinic Acid Aided Resection Margins in Sarcoma · EARLY_PHASE1 · not yet recruiting
- NCT07279558 — Cannabidiol and Alcohol Use Disorder Phenotypes · Phase 2 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05619419 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Colorado, Denver
- Last refreshed: 22 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05619419.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing